{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:25:49Z","timestamp":1773797149685,"version":"3.50.1"},"reference-count":36,"publisher":"Impact Journals, LLC","issue":"50","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2020,12,15]]},"DOI":"10.18632\/oncotarget.27834","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T16:01:53Z","timestamp":1608048113000},"page":"4607-4612","source":"Crossref","is-referenced-by-count":11,"title":["Immune-stimulatory (TK\/Flt3L) gene therapy opens the door to a promising new treatment strategy against brainstem gliomas"],"prefix":"10.18632","volume":"11","author":[{"given":"Syed M.","family":"Faisal","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA"},{"name":"Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flor M.","family":"Mendez","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA"},{"name":"Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Nunez","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA"},{"name":"Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria G.","family":"Castro","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA"},{"name":"Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro R.","family":"Lowenstein","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA"},{"name":"Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"13","author":"Ellison","year":"2016","journal-title":"Acta Neuropathol"},{"key":"2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"48","author":"Kool","year":"2012","journal-title":"Nature"},{"key":"3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"4","author":"Dyer","year":"2012","journal-title":"Nat Genet"},{"key":"4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"12","author":"Montpetit","year":"2012","journal-title":"Acta Neuropathol"},{"key":"5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00401-019-01975-4","article-title":"H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth","volume":"13","author":"Boggs","year":"2019","journal-title":"Acta Neuropathol"},{"key":"6","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1038\/s41467-019-10043-0","article-title":"The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models","volume":"1","author":"Tejada-Solis","year":"2019","journal-title":"Nat Commun"},{"key":"7","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/neuros\/nyx507","article-title":"Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients","volume":"8","author":"Diez-Valle","year":"2018","journal-title":"Neurosurgery"},{"key":"8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neo.2015.12.002","article-title":"A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells","volume":"1","author":"Becher","year":"2016","journal-title":"Neoplasia"},{"key":"9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00401-014-1319-6","article-title":"Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications","volume":"12","author":"Hawkins","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/neuonc\/noaa003","article-title":"Modeling DIPG in the mouse brainstem","volume":"2","author":"Hawkins","year":"2020","journal-title":"Neuro Oncol"},{"key":"11","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1158\/1078-0432.CCR-18-3890","article-title":"Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma","volume":"2","author":"Seluanov","year":"2019","journal-title":"Clin Cancer Res"},{"key":"12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s42003-019-0420-8","article-title":"ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma","volume":"2","author":"Raynaud","year":"2019","journal-title":"Commun Biol"},{"key":"13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1126\/science.1232245","article-title":"Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma","volume":"34","author":"Allis","year":"2013","journal-title":"Science"},{"key":"14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"4","author":"Ryall","year":"2014","journal-title":"Nat Genet"},{"key":"15","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1158\/0008-5472.CAN-14-1298","article-title":"ACVR1 mutations in DIPG: lessons learned from FOP","volume":"7","author":"Jones","year":"2014","journal-title":"Cancer Res"},{"key":"16","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/ng.2950","article-title":"Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma","volume":"4","author":"Sturm","year":"2014","journal-title":"Nat Genet"},{"key":"17","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ng.2938","article-title":"The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma","volume":"4","author":"Ma","year":"2014","journal-title":"Nat Genet"},{"key":"18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ng.2925","article-title":"Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma","volume":"4","author":"Cruz","year":"2014","journal-title":"Nat Genet"},{"key":"19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fonc.2015.00172","article-title":"Pre-Clinical Models of Diffuse Intrinsic Pontine Glioma","volume":"5","author":"Becher","year":"2015","journal-title":"Front Oncol"},{"key":"20","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1158\/1541-7786.MCR-16-0389","article-title":"Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG","volume":"1","author":"Becher","year":"2017","journal-title":"Mol Cancer Res"},{"key":"21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41467-019-08823-9","article-title":"ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis","volume":"1","author":"Becher","year":"2019","journal-title":"Nat Commun"},{"key":"22","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ccell.2017.09.014","article-title":"H3.3(K27M) Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas","volume":"3","author":"Khazaei","year":"2017","journal-title":"Cancer Cell"},{"key":"23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/neuonc\/noz197","article-title":"Generation of diffuse intrinsic pontine glioma mouse models by brainstem-targeted in utero electroporation","volume":"2","author":"Phoenix","year":"2020","journal-title":"Neuro Oncol"},{"key":"24","doi-asserted-by":"publisher","first-page":"e0170501","DOI":"10.1371\/journal.pone.0170501","article-title":"Development of a DIPG Orthotopic Model in Mice Using an Implantable Guide-Screw System","volume":"1","author":"Tejada-Solis","year":"2017","journal-title":"PLoS One"},{"key":"25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40478-019-0714-6","article-title":"Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models","volume":"7","author":"Alonso","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00401-020-02171-5","article-title":"Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource","volume":"14","author":"Upadayaya","year":"2020","journal-title":"Acta Neuropathol"},{"key":"27","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1158\/1078-0432.CCR-19-3714","article-title":"Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK\/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma","volume":"2","author":"Castro","year":"2020","journal-title":"Clinical Cancer Research"},{"key":"28","article-title":"Genetically Engineered Mouse Model of Brainstem High-Grade Glioma","author":"Castro","year":"2020","journal-title":"Star Protocol"},{"key":"29","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1158\/0008-5472.CAN-04-3434","article-title":"Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model","volume":"6","author":"Lassmann","year":"2005","journal-title":"Cancer Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1158\/1078-0432.CCR-09-0155","article-title":"Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity","volume":"1","author":"Lerner","year":"2009","journal-title":"Clin Cancer Res"},{"key":"31","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1158\/1078-0432.CCR-13-2140","article-title":"Temozolomide does not impair gene therapy-mediated antitumor immunity in syngeneic brain tumor models","volume":"2","author":"Castro","year":"2014","journal-title":"Clin Cancer Res"},{"key":"32","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.1158\/1078-0432.CCR-09-1087","article-title":"Antiglioma immunological memory in response to conditional cytotoxic\/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regression","volume":"1","author":"Van Rooijen","year":"2009","journal-title":"Clin Cancer Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s13311-012-0144-7","article-title":"Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-\u03baB signaling improves the efficacy of immunotherapy in a brain cancer model","volume":"9","author":"Curran","year":"2012","journal-title":"Neurotherapeutics"},{"key":"34","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s40425-019-0673-2","article-title":"Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity","volume":"7","author":"Vile","year":"2019","journal-title":"J Immunother Cancer"},{"key":"35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/neuonc\/noy145","article-title":"Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy","volume":"2","author":"Crane","year":"2019","journal-title":"Neuro Oncol"},{"key":"36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40478-018-0553-x","article-title":"Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma","volume":"6","author":"Monje","year":"2018","journal-title":"Acta Neuropathol Commun"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T16:01:59Z","timestamp":1608048119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":36,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2020,12,15]]}},"alternative-id":["27834"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.27834","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,15]]}}}